🇺🇸 FDA
Patent

US 10328161

Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof

granted A61KA61K31/427A61K49/0017

Quick answer

US patent 10328161 (Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof) held by The Regents of the University of California expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/427, A61K49/0017, A61K49/0021